Imaging to Differentiate Between Ischemic and Nonischemic Cardiomyopathy

Heart Failure Clinics

Volumn 2, Issue 2, 2006, Pages 205-214

  Bax, Jeroen J ^a   Poldermans, Don ^b   Schuijf, Joanne D ^a   Scholte, Arthur J H A ^a   Elhendy, Abdou ^b   van der Wall, Ernst E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; SPIRONOLACTONE;

CARDIOMYOPATHY; CLINICAL TRIAL; CORONARY ARTERY; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; HYPOKALEMIA; IMAGING; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SENSITIVITY AND SPECIFICITY;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; HEART TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 33744736591     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2006.01.003     Document Type: Review

References (42)

1. American Heart Association. Heart disease and stroke statistics, 2005 update (2005), American Heart Association, Dallas (TX)
2. Gheorghiade M., and Bonow R.O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97 (1998) 282-289
3. Anderson K.M., Kannel W.B., Grossman W., et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88 (1993) 107-115
4. Cowie M.R., Wood D.A., Coats A.J., et al. Incidence and aetiology of heart failure: a population-based study. Eur Heart J 20 (1999) 421-428
5. Khand A., Gemmel I., Clark A., et al. Is the prognosis of heart failure improving?. J Am Coll Cardiol 36 (2000) 2284-2286
6. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327 (1992) 669-677
7. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
8. Pitt B., Poole-Wilson P.A., Segal R., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Study ELITE II. Lancet 355 (2000) 1582-1587
9. Braunwald E. Expanding indications for beta-blockers in heart failure. N Engl J Med 344 (2001) 1711-1712
10. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
11. Juurlink D.N., Mamdani M.M., Lee D.S., et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351 (2004) 543-551
12. Caims J.A., Connolly S.J., Roberts R., et al., for the CAMIAT investigators. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive premature depolarizations. Lancet 349 (1997) 675-682
13. Evans R.W., Manninen D.L., Garrison L.P., et al. Donor availability as the primary determinant of the future of heart transplantation. JAMA 255 (1986) 1892-1898
14. Rahimtoola S.H. The hibernating myocardium. Am Heart J 117 (1989) 211-221
15. Romano M.A., and Bolling S.F. Update on mitral repair in dilated cardiomyopathy. J Card Surg 19 (2004) 396-400
16. Horii T., Isomura T., Komeda M., et al. Left ventriculoplasty for nonischemic dilated cardiomyopathy. J Card Surg 18 (2003) 121-124
17. Auricchio A., and Abraham W.T. Cardiac resynchronization therapy: current state of the art: cost versus benefit. Circulation 109 (2004) 300-307
18. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
19. Molhoek S.G., Bax J.J., Van Erven L., et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 93 (2004) 860-863
20. Schinkel A.F., Bax J.J., Boersma E., et al. Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction. Am Heart J 144 (2002) 865-869
21. Schuijf J.D., Shaw L.J., Wijns W., et al. Cardiac imaging in coronary artery disease: differing modalities. Heart 91 (2005) 1110-1117
22. Sharp S.M., Sawada S.G., Segar D.S., et al. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 24 (1994) 934-939
23. Kaul S. Echocardiographic insights into regional flow-function relationships in coronary artery disease. J Nucl Cardiol 12 (2005) 216-226
24. Peltier M., Vancraeynest D., Pasquet A., et al. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography: comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J Am Coll Cardiol 43 (2004) 257-264
25. Senior R., Janardhanan R., Jeetley P., et al. Myocardial contrast echocardiography for distinguishing ischemic from nonischemic first-onset acute heart failure: insights into the mechanism of acute heart failure. Circulation 112 (2005) 1587-1593
26. Sawada S.G., Ryan T., Segar D., et al. Distinguishing ischemic cardiomyopathy from nonischemic dilated cardiomyopathy with coronary echocardiography. J Am Coll Cardiol 19 (1992) 1223-1228
27. Caiati C., Montaldo C., Zedda N., et al. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 99 (1999) 771-778
28. Caiati C., Montaldo C., Zedda N., et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. J Am Coll Cardiol 34 (1999) 1193-1200
29. Ruscazio M., Montisci R., Colonna P., et al. Detection of coronary restenosis after coronary angioplasty by contrast-enhanced transthoracic echocardiographic Doppler assessment of coronary flow velocity reserve. J Am Coll Cardiol 40 (2002) 896-903
30. Smanio P.E., Watson D.D., Segalla D.L., et al. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 30 (1997) 1687-1692
31. Eichhorn E.J., Kosinski E.J., Lewis S.M., et al. Usefulness of dipyridamole-thallium-201 perfusion scanning for distinguishing ischemic from nonischemic cardiomyopathy. Am J Cardiol 62 (1988) 945-951
32. Danias P.G., Ahlberg A.W., Clark III B.A., et al. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 82 (1998) 1253-1258
33. Danias P.G., Papaioannou G.I., Ahlberg A.W., et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol 94 (2004) 14-19
34. Eisenberg J.D., Sobel B.E., and Geltman E.M. Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography. Am J Cardiol 59 (1987) 1410-1414
35. Mody F.V., Brunken R.C., Stevenson L.W., et al. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol 17 (1991) 373-383
36. Berry J.J., Hoffman J.M., Steenbergen C., et al. Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. J Nucl Med 34 (1993) 39-47
37. Beanlands R.S., Bach D.S., Raylman R., et al. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 22 (1993) 1389-1398
38. Young A.A., Dokos S., Powell K.A., et al. Regional heterogeneity of function in nonischemic dilated cardiomyopathy. Cardiovasc Res 49 (2001) 308-318
39. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
40. McCrohon J.A., Moon J.C., Prasad S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003) 54-59
41. Mollet N.R., Cademartiri F., Van Mieghem C.A., et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation 112 (2005) 2318-2323
42. Budoff M.J., Shavelle D.M., Lamont D.H., et al. Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. J Am Coll Cardiol 32 (1998) 1173-1178